Close Menu


The Associated Press reports European Union regulators have authorized the SARS-CoV-2 vaccine from AstraZeneca and Oxford University.

The Verge reports that the EU-UK trade deal includes a provision that the transfer of DNA profiles rely on outdated email software.

ScienceInsider reports that the UK-EU trade deal allows UK researchers access to EU research funding.

Earlier this year, Novigenix and collaborators were awarded up to €1 million to develop a blood-based multi-omics colorectal cancer assay.

Science reports that the Horizon Europe budget has increased by €4 billion, but that basic research institutions may see a decline in funds next year.

Not Convened

Science reports the US Food and Drug Administration did not consult an outside panel in its approval of remdesivir as a COVID-19 treatment.

The UK and the European Union have come to a sticking point in the negotiation of how the UK might remain involved in the Horizon Europe research program, the Guardian reports.

According to the Guardian, more than 150 countries have signed on to a global SARS-CoV-2 vaccine plan.

The research network said in a statement that precision breeding techniques are needed to achieve the UN's Sustainable Development Goals.

A European Union budget deal provides less funding than expected for its Horizon Europe research program, according to Science.


Forbes reports that a structural biology lab at Oxford University studying the coronavirus was hacked.

Politico reports that the NYPD DNA database has grown since it announced it would be removing profiles from it.

Science reports that a Dutch research funding agency is combating a ransomware attack.

In Science this week: set of 64 haplotype assemblies from 32 individuals, and more.